GT Biopharma, Inc. Financial Ratios
GTBP|FY2020 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2020 SEC 10-K data.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2020)
Return on Equity
-
Profit Margin
-
Net Income / Revenue
Asset Turnover
-
Revenue / Total Assets
Equity Multiplier
-
Total Assets / Equity
Profitability
Gross Margin
-
Operating Margin
-
EBITDA
-$40.8M
EBITDA Margin
-
Liquidity
Current Ratio
0.16
Quick Ratio
0.16
Solvency
Interest Coverage
1.72
Efficiency
Asset Turnover
-
Inventory Turnover
-
Days Sales Outstanding
-
As of FY2020 · SEC 10-K · Updated Jun 24, 2026